MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 78 filers reported holding MELINTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $613,000 | -78.6% | 772,725 | +6.8% | 0.00% | -100.0% |
| Q3 2018 | $2,859,000 | -16.9% | 723,818 | +33.6% | 0.00% | 0.0% |
| Q2 2018 | $3,439,000 | -2.4% | 541,583 | +13.7% | 0.00% | 0.0% |
| Q1 2018 | $3,524,000 | -48.2% | 476,212 | +10.6% | 0.00% | -66.7% |
| Q4 2017 | $6,801,000 | – | 430,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISTHMUS PARTNERS, LLC | 84,072 | $7,657,000 | 1.86% |
| Sterling Investment Advisors, Ltd. | 19 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |